Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Choosing PET over SPECT | CCTA & low-risk patients | Medtronic makes a move | Reducing invasive catheterizations | AI for POCUS
Friday, February 13, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Cardiac Imaging

ASNC says PET is now the preferred nuclear imaging test for CAD

Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.

READ MORE >
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
Share on Twitter Share on Facebook Share on Linkedin

ASNC says PET is now the preferred nuclear imaging test for CAD

Share on Twitter Share on Facebook Share on Linkedin
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.
READ MORE >

CCTA delivers value, even when treating low-risk patients with no history of CAD

Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.

READ MORE >
Radiology technologists starts an IV for a patient on a CT scanner at Wellstar Kennestone Hospital. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

CCTA delivers value, even when treating low-risk patients with no history of CAD

Share on Twitter Share on Facebook Share on Linkedin
Radiology technologists starts an IV for a patient on a CT scanner at Wellstar Kennestone Hospital. Photo by Dave Fornell
Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.
READ MORE >

Medtronic to acquire AI-enabled FFR specialists CathWorks for up to $585M

Medtronic has held a minority investment in CathWorks for several years, and the two organizations entered into a co-promotion agreement in 2022. Once finalized, the move will increase Medtronic's presence in the cath lab. 

READ MORE >
artificial intelligence money finance acquisition
Share on Twitter Share on Facebook Share on Linkedin

Medtronic to acquire AI-enabled FFR specialists CathWorks for up to $585M

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence money finance acquisition
Medtronic has held a minority investment in CathWorks for several years, and the two organizations entered into a co-promotion agreement in 2022. Once finalized, the move will increase Medtronic's presence in the cath lab. 
READ MORE >

MRI scans evaluate heart failure risk—no invasive catheterization required

Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations.

READ MORE >
Researchers in the U.K. from Newcastle University, University of Leeds, and the University of East Anglia found they could use cardiovascular magnetic resonance (CMR) T2 intracardiac blood pool data to create imaging-derived SvO2 (iSvO2) noninvasively.
Share on Twitter Share on Facebook Share on Linkedin

MRI scans evaluate heart failure risk—no invasive catheterization required

Share on Twitter Share on Facebook Share on Linkedin
Researchers in the U.K. from Newcastle University, University of Leeds, and the University of East Anglia found they could use cardiovascular magnetic resonance (CMR) T2 intracardiac blood pool data to create imaging-derived SvO2 (iSvO2) noninvasively.
Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations.
READ MORE >

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.

READ MORE >
The U.S. Food and Drug Administration (FDA) has cleared HeartLung Corporation's AI-CVD, an artificial intelligence (AI) algorithm that looks at 11 different opportunistic health screening assessments on chest CT exams ordered for any reason.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has cleared HeartLung Corporation's AI-CVD, an artificial intelligence (AI) algorithm that looks at 11 different opportunistic health screening assessments on chest CT exams ordered for any reason.
“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.
READ MORE >

ASNC reports shortage of cardiac amyloidosis radiotracers

The two vendors involved say supplies of PYP and HDP could be disrupted for months.

READ MORE >
cardiac amyloidosis on bone scan. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.
Share on Twitter Share on Facebook Share on Linkedin

ASNC reports shortage of cardiac amyloidosis radiotracers

Share on Twitter Share on Facebook Share on Linkedin
cardiac amyloidosis on bone scan. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.
The two vendors involved say supplies of PYP and HDP could be disrupted for months.
READ MORE >

AI model turns POCUS images into accurate structural heart evaluations

Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.

READ MORE >
AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.
Share on Twitter Share on Facebook Share on Linkedin

AI model turns POCUS images into accurate structural heart evaluations

Share on Twitter Share on Facebook Share on Linkedin
AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.
Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.
READ MORE >

Cardiac imaging registry expands to include former NBA, NHL players

Former NBA player Muggsy Bogues, who also acted in the 1996 film Space Jam, is one of many athletes now participating in the registry. "I’ve lost too many friends to cardiovascular disease," he said. 

READ MORE >
older basketball player
Share on Twitter Share on Facebook Share on Linkedin

Cardiac imaging registry expands to include former NBA, NHL players

Share on Twitter Share on Facebook Share on Linkedin
older basketball player
Former NBA player Muggsy Bogues, who also acted in the 1996 film Space Jam, is one of many athletes now participating in the registry. "I’ve lost too many friends to cardiovascular disease," he said. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup